Researchers have developed a new approach that might help ALS patients maintain their ability to communicate as disease progresses, according to a study published in the Journal of Neural Engineering. In the research paper, “Self-Regulation Of Brain Rhythms In The Precuneus: A Novel BCI Paradigm For Patients…
News
Long-term use of Rilutek (riluzole) is associated with a better outcome in sporadic amyotrophic lateral sclerosis (ALS) patients, whereas short-term use seems to have little effect on survival according to a study published in the scientific journal Frontiers in Aging Neuroscience.
The ALS Association is awarding a $2 million grant to the ALS ONE-Massachusetts Partnership that will partially sponsor a University of Massachusetts Medical School project led by Robert H. Brown, Jr., MD, PhD, a world-renowned specialist in amyotrophic lateral sclerosis (ALS). The grant will help Brown and colleagues develop two gene…
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion recommending that ibudilast (MN-166) receives orphan medicinal product (orphan drug designation) for the treatment of amyotrophic lateral sclerosis (ALS). MediciNova is currently focusing on the development of ibudilast for neurological disorders…
A woman with amyotrophic lateral sclerosis (ALS), who had lost nearly all capacity to communicate, is now able to successfully interact with her surroundings using a brain-computer interface implant, according to a recent article in New Scientist magazine. The device is thought to be the first used in a patient’s daily life, without the need…
News
Iron-Based Proteins In the Brain May Be Biomarker for ALS Diagnosis and Progression, Study Concludes
Researchers in China recently evaluated the changes of ferritin levels in the brain’s cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). They found that ALS patients exhibited significantly increased levels of ferritin, an iron-based protein, a result that indicates ferritin has value as a biomarker and could be used for…
Researchers at Nagoya University in Japan, in collaboration with several U.S. institutions, suggest that the collapse of the mitochondria‐associated membranes (MAM) is linked to the development of amyotrophic lateral sclerosis (ALS). Mitochondria‐associated membranes regulate calcium levels, mitochondrial function, and cell death in the body, and have been linked to neurodegenerative…
New research points to evidence that physical fitness, body mass index (BMI), IQ, and stress resilience in young adults might play a role in the development of amyotrophic lateral sclerosis (ALS). The study, “Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an…
Incorporating music therapy into standard treatments for amyotrophic lateral sclerosis (ALS) patients may improve the patient’s quality of life, according to new research. The study, “Active Music Therapy Approach In Amyotrophic Lateral Sclerosis: A Randomized-Controlled Trial,” was published in the International Journal of Rehabilitation Research. “[T]he sonorous-music and…
Researchers have identified several new variants in genes associated with amyotrophic lateral sclerosis (ALS), many in patients with no history of the disease in their family. The study, “Rare Variants In Neurodegeneration Associated Genes Revealed By Targeted Panel Sequencing In A German ALS Cohort,” was published in the journal Frontiers…
Recent Posts
- New funding backs commercial readiness efforts for ALS therapy
- US lawmakers reintroduce bill to improve access to treatment for ALS
- An emotional dance performance mirrored my life with ALS
- Expanded access program for ALS drug MN-166 at 50% enrollment
- US clinical trials lack diverse representation of ALS patients